TreeWAS – Variant ID: rs73045269

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R31 Unspecified haematuria	0.000	0.000	1.000
I20 Angina pectoris	1.000	0.000	0.000
I25 Chronic ischaemic heart disease	0.999	0.001	0.000
I20-I25 Ischaemic heart diseases	0.999	0.001	0.000
I25.1 Atherosclerotic heart disease	0.999	0.001	0.000
I20.9 Angina pectoris, unspecified	0.998	0.002	0.000
I20.0 Unstable angina	0.995	0.005	0.000
I25.9 Chronic ischaemic heart disease, unspecified	0.971	0.029	0.000
I20.8 Other forms of angina pectoris	0.949	0.051	0.000
I25.0 Atherosclerotic cardiovascular disease, so described	0.851	0.149	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.816	0.184	0.000
I24 Other acute ischaemic heart diseases	0.779	0.221	0.000
I21 Acute myocardial infarction	0.773	0.227	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.745	0.255	0.000
I21.2 Acute transmural myocardial infarction of other sites	0.735	0.265	0.000
I25.3 Aneurysm of heart	0.724	0.276	0.000
I25.6 Silent myocardial ischaemia	0.716	0.283	0.000
I21.1 Acute transmural myocardial infarction of inferior wall	0.696	0.304	0.000
I25.5 Ischaemic cardiomyopathy	0.675	0.325	0.000
I23 Certain current complications following acute myocardial infarction	0.648	0.352	0.000
I25.4 Coronary artery aneurysm	0.634	0.366	0.000
I22 Subsequent myocardial infarction	0.602	0.398	0.000
I24.1 Dressler's syndrome	0.556	0.444	0.000
I21.X Presumed acute myicardial infaction (unconfirmed)	0.554	0.446	0.000
I21.3 Acute transmural myocardial infarction of unspecified site	0.490	0.510	0.000
I22.0 Subsequent myocardial infarction of anterior wall	0.486	0.514	0.000
I21.0 Acute transmural myocardial infarction of anterior wall	0.484	0.516	0.000
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.464	0.535	0.000
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.464	0.535	0.000
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.464	0.535	0.000
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.464	0.535	0.000
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.464	0.535	0.000
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.464	0.535	0.000
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.464	0.535	0.000
I20.1 Angina pectoris with documented spasm	0.449	0.551	0.000
I22.1 Subsequent myocardial infarction of inferior wall	0.444	0.556	0.000
I23.8 Other current complications following acute myocardial infarction	0.396	0.604	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.383	0.617	0.000
I22.8 Subsequent myocardial infarction of other sites	0.351	0.648	0.000
I22.9 Subsequent myocardial infarction of unspecified site	0.295	0.705	0.000
I21.4 Acute subendocardial myocardial infarction	0.293	0.707	0.000
I24.8 Other forms of acute ischaemic heart disease	0.221	0.779	0.000
I25.2 Old myocardial infarction	0.147	0.853	0.000
R30-R39 Symptoms and signs involving the urinary system	0.000	0.934	0.066
R39 Other symptoms and signs involving the urinary system	0.000	0.939	0.061
G20 Parkinson's disease	0.000	0.940	0.060
R39.1 Other difficulties with micturition	0.000	0.940	0.060
I21.9 Acute myocardial infarction, unspecified	0.057	0.943	0.000
R34 Anuria and oliguria	0.000	0.948	0.052
R39.0 Extravasation of urine	0.000	0.955	0.045
R39.2 Extrarenal uraemia	0.000	0.956	0.044
U80.0 Penicillin resistant agent	0.042	0.958	0.000
Z95.5 Presence of coronary angioplasty implant and graft	0.042	0.958	0.000
R36 Urethral discharge	0.000	0.963	0.037
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.036	0.964	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.035	0.965	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.035	0.965	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.035	0.965	0.000
R39.8 Other and unspecified symptoms and signs involving the urinary system	0.000	0.967	0.033
R30 Pain associated with micturition	0.000	0.967	0.033
T40.4 Other synthetic narcotics	0.033	0.967	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.032	0.968	0.000
T40.2 Other opioids	0.031	0.969	0.000
T40.5 Cocaine	0.031	0.969	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.031	0.969	0.000
R35 Polyuria	0.000	0.970	0.030
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.029	0.971	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.029	0.971	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.028	0.972	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.028	0.972	0.000
R30.9 Painful micturition, unspecified	0.000	0.972	0.028
T46 Poisoning by agents primarily affecting the cardiovascular system	0.028	0.972	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.027	0.973	0.000
T36 Poisoning by systemic antibiotics	0.026	0.974	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.026	0.974	0.000
T38.1 Thyroid hormones and substitutes	0.026	0.974	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.025	0.974	0.000
T40.8 Lysergide [LSD]	0.025	0.974	0.000
T40.7 Cannabis (derivatives)	0.025	0.974	0.000
T40.3 Methadone	0.025	0.974	0.000
T40.1 Heroin	0.025	0.974	0.000
T40.0 Opium	0.025	0.974	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.025	0.974	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.025	0.975	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.025	0.975	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.025	0.975	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.025	0.975	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.025	0.975	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.025	0.975	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.025	0.975	0.000
T44.0 Anticholinesterase agents	0.025	0.975	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.025	0.975	0.000
T50.4 Drugs affecting uric acid metabolism	0.025	0.975	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.025	0.975	0.000
T48.5 Anti-common-cold drugs	0.025	0.975	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.024	0.976	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.024	0.976	0.000
T40.6 Other and unspecified narcotics	0.024	0.976	0.000
T50.8 Diagnostic agents	0.023	0.977	0.000
T38.9 Other and unspecified hormone antagonists	0.023	0.977	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.023	0.977	0.000
T38.7 Androgens and anabolic congeners	0.023	0.977	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.023	0.977	0.000
T38.5 Other oestrogens and progestogens	0.023	0.977	0.000
T38.4 Oral contraceptives	0.023	0.977	0.000
T38.2 Antithyroid drugs	0.023	0.977	0.000
T38.0 Glucocorticoids and synthetic analogues	0.023	0.977	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.023	0.977	0.000
G20-G26 Extrapyramidal and movement disorders	0.000	0.977	0.023
U80 Agent resistant to penicillin and related antibiotics	0.022	0.978	0.000
T50.7 Analeptics and opioid receptor antagonists	0.022	0.978	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.022	0.978	0.000
T50.5 Appetite depressants	0.022	0.978	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.022	0.978	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.022	0.978	0.000
T50.1 Loop [high-ceiling] diuretics	0.022	0.978	0.000
T50.0 Mineralocorticoids and their antagonists	0.022	0.978	0.000
T45.0 Antiallergic and antiemetic drugs	0.022	0.978	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.021	0.978	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.021	0.979	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.021	0.979	0.000
T48.4 Expectorants	0.021	0.979	0.000
T48.3 Antitussives	0.021	0.979	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.021	0.979	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.021	0.979	0.000
T48.0 Oxytocic drugs	0.021	0.979	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.021	0.979	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.021	0.979	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.021	0.979	0.000
T37.5 Antiviral drugs	0.021	0.979	0.000
T37.4 Anthelminthics	0.021	0.979	0.000
T37.3 Other antiprotozoal drugs	0.021	0.979	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.021	0.979	0.000
T37.1 Antimycobacterial drugs	0.021	0.979	0.000
T37.0 Sulphonamides	0.021	0.979	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.021	0.979	0.000
T49.9 Topical agent, unspecified	0.020	0.980	0.000
T49.8 Other topical agents	0.020	0.980	0.000
T49.7 Dental drugs, topically applied	0.020	0.980	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.020	0.980	0.000
T49.5 Ophthalmological drugs and preparations	0.020	0.980	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.020	0.980	0.000
T49.3 Emollients, demulcents and protectants	0.020	0.980	0.000
T49.2 Local astringents and local detergents	0.020	0.980	0.000
T49.1 Antipruritics	0.020	0.980	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.020	0.980	0.000
D13.1 Stomach	0.000	0.980	0.020
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.020	0.980	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.020	0.980	0.000
T46.7 Peripheral vasodilators	0.020	0.980	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.020	0.980	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.020	0.980	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.020	0.980	0.000
T46.1 Calcium-channel blockers	0.020	0.980	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.019	0.980	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.019	0.980	0.000
T47.7 Emetics	0.019	0.980	0.000
T47.6 Antidiarrhoeal drugs	0.019	0.980	0.000
T47.5 Digestants	0.019	0.980	0.000
T47.4 Other laxatives	0.019	0.980	0.000
T47.3 Saline and osmotic laxatives	0.019	0.980	0.000
T47.2 Stimulant laxatives	0.019	0.980	0.000
T47.0 Histamine H(2)-receptor antagonists	0.019	0.980	0.000
G24 Dystonia	0.000	0.980	0.020
T39.1 4-Aminophenol derivatives	0.020	0.980	0.000
T36.0 Penicillins	0.019	0.981	0.000
T39.0 Salicylates	0.019	0.981	0.000
R30.1 Vesical tenesmus	0.000	0.981	0.019
T36.9 Systemic antibiotic, unspecified	0.019	0.981	0.000
T36.8 Other systemic antibiotics	0.019	0.981	0.000
T36.7 Antifungal antibiotics, systemically used	0.019	0.981	0.000
T36.6 Rifamycins	0.019	0.981	0.000
T36.5 Aminoglycosides	0.019	0.981	0.000
T36.4 Tetracyclines	0.019	0.981	0.000
T36.3 Macrolides	0.019	0.981	0.000
T36.2 Chloramphenicol group	0.019	0.981	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.019	0.981	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.019	0.981	0.000
T45.8 Other primarily systemic and haematological agents	0.019	0.981	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.019	0.981	0.000
T45.6 Fibrinolysis-affecting drugs	0.019	0.981	0.000
T45.4 Iron and its compounds	0.019	0.981	0.000
T45.3 Enzymes, not elsewhere classified	0.019	0.981	0.000
T41.5 Therapeutic gases	0.018	0.981	0.000
T41.4 Anaesthetic, unspecified	0.018	0.981	0.000
T41.3 Local anaesthetics	0.018	0.981	0.000
T41.2 Other and unspecified general anaesthetics	0.018	0.981	0.000
T41.1 Intravenous anaesthetics	0.018	0.981	0.000
T41.0 Inhaled anaesthetics	0.018	0.981	0.000
T39.4 Antirheumatics, not elsewhere classified	0.018	0.982	0.000
T39.2 Pyrazolone derivatives	0.018	0.982	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.018	0.982	0.000
T45.5 Anticoagulants	0.018	0.982	0.000
T45.2 Vitamins, not elsewhere classified	0.018	0.982	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.017	0.983	0.000
G24.5 Blepharospasm	0.000	0.983	0.017
R32 Unspecified urinary incontinence	0.000	0.983	0.017
G23 Other degenerative diseases of basal ganglia	0.000	0.983	0.016
G21 Secondary Parkinsonism	0.000	0.983	0.016
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.000	0.983	0.016
G22 Parkinsonism in diseases classified elsewhere	0.000	0.983	0.016
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.016	0.984	0.000
G24.9 Dystonia, unspecified	0.000	0.985	0.015
T45.1 Antineoplastic and immunosuppressive drugs	0.015	0.985	0.000
U51 Admission status on psychiatric patients	0.014	0.986	0.000
G24.4 Idiopathic orofacial dystonia	0.000	0.986	0.014
G24.3 Spasmodic torticollis	0.000	0.986	0.014
G24.2 Idiopathic nonfamilial dystonia	0.000	0.986	0.014
G24.1 Idiopathic familial dystonia	0.000	0.986	0.014
G24.0 Drug-induced dystonia	0.000	0.986	0.014
G24.8 Other dystonia	0.000	0.986	0.014
U80.8 Agent resistant to other penicillin-related antibiotic	0.013	0.987	0.000
Z95.1 Presence of aortocoronary bypass graft	0.013	0.987	0.000
T43.6 Psychostimulants with abuse potential	0.013	0.987	0.000
K81.1 Chronic cholecystitis	0.000	0.987	0.013
T43.9 Psychotropic drug, unspecified	0.013	0.987	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.013	0.987	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.013	0.987	0.000
T43.2 Other and unspecified antidepressants	0.013	0.987	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.012	0.987	0.000
U80.1 Methicillin resistant agent	0.012	0.988	0.000
G21.9 Secondary Parkinsonism, unspecified	0.000	0.988	0.012
G21.8 Other secondary Parkinsonism	0.000	0.988	0.012
G21.4 Vascular parkinsonism	0.000	0.988	0.012
G21.3 Postencephalitic Parkinsonism	0.000	0.988	0.012
G21.2 Secondary Parkinsonism due to other external agents	0.000	0.988	0.012
G21.1 Other drug-induced secondary Parkinsonism	0.000	0.988	0.012
G21.0 Malignant neuroleptic syndrome	0.000	0.988	0.012
G23.9 Degenerative disease of basal ganglia, unspecified	0.000	0.988	0.012
G23.8 Other specified degenerative diseases of basal ganglia	0.000	0.988	0.012
G23.3 Multiple system atrophy, cerebellar type	0.000	0.988	0.012
G23.2 Striatonigral degeneration	0.000	0.988	0.012
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]	0.000	0.988	0.012
G23.0 Hallervorden-Spatz disease	0.000	0.988	0.012
U51.1 Previously admitted to a psychiatric hospital of the provider	0.012	0.988	0.000
U50 Level of care administered to neonates	0.012	0.988	0.000
U07 Emergency use of U07	0.012	0.988	0.000
U06 Emergency use of U06	0.012	0.988	0.000
U04 Severe acute respiratory syndrome [SARS]	0.012	0.988	0.000
U52 First in a series of a regular day/night admissions	0.012	0.988	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.012	0.988	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.012	0.988	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.012	0.988	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.012	0.988	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.011	0.989	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.010	0.989	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.010	0.989	0.000
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.000	0.990	0.010
Chapter XXII Codes for special purposes	0.010	0.990	0.000
M77.12 Lateral epicondylitis (Upper arm)	0.009	0.991	0.000
D13.5 Extrahepatic bile ducts	0.000	0.991	0.009
M13.99 Arthritis, unspecified (Site unspecified)	0.000	0.991	0.009
Z95 Presence of cardiac and vascular implants and grafts	0.009	0.991	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.009	0.991	0.000
U06.9 Emergency use of U06.9	0.009	0.991	0.000
U06.8 Emergency use of U06.8	0.009	0.991	0.000
U06.7 Emergency use of U06.7	0.009	0.991	0.000
U06.6 Emergency use of U06.6	0.009	0.991	0.000
U06.5 Emergency use of U06.5	0.009	0.991	0.000
U06.4 Emergency use of U06.4	0.009	0.991	0.000
U06.3 Emergency use of U06.3	0.009	0.991	0.000
U06.2 Emergency use of U06.2	0.009	0.991	0.000
U06.1 Emergency use of U06.1	0.009	0.991	0.000
U06.0 Emergency use of U06.0	0.009	0.991	0.000
U07.9 Emergency use of U07.9	0.009	0.991	0.000
U07.8 Emergency use of U07.8	0.009	0.991	0.000
U07.7 Emergency use of U07.7	0.009	0.991	0.000
U07.6 Emergency use of U07.6	0.009	0.991	0.000
U07.5 Emergency use of U07.5	0.009	0.991	0.000
U07.4 Emergency use of U07.4	0.009	0.991	0.000
U07.3 Emergency use of U07.3	0.009	0.991	0.000
U07.2 Emergency use of U07.2	0.009	0.991	0.000
U07.1 Emergency use of U07.1	0.009	0.991	0.000
U07.0 Emergency use of U07.0	0.009	0.991	0.000
U50.9 Inquest Adjourned Death	0.009	0.991	0.000
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.009	0.991	0.000
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.009	0.991	0.000
U50.1 Level of care administered to neonates (Special Care)	0.009	0.991	0.000
U50.0 Level of care administered to neonates (Normal Care)	0.009	0.991	0.000
L71.9 Rosacea, unspecified	0.009	0.991	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.009	0.991	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.009	0.991	0.000
T42.3 Barbiturates	0.009	0.991	0.000
T42.2 Succinimides and oxazolidinediones	0.009	0.991	0.000
D13.2 Duodenum	0.000	0.991	0.009
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.009	0.991	0.000
G25 Other extrapyramidal and movement disorders	0.000	0.992	0.008
T42.1 Iminostilbenes	0.008	0.992	0.000
U88 Agent resistant to multiple antibiotics	0.008	0.992	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.008	0.992	0.000
D13.0 Oesophagus	0.000	0.992	0.008
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.008	0.992	0.000
D13.7 Endocrine pancreas	0.000	0.992	0.008
T42.0 Hydantoin derivatives	0.007	0.992	0.000
D13.6 Pancreas	0.000	0.992	0.008
N28.1 Cyst of kidney, acquired	0.000	0.992	0.008
D13.9 Ill-defined sites within the digestive system	0.000	0.993	0.007
D13.3 Other and unspecified parts of small intestine	0.000	0.993	0.007
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.007	0.993	0.000
Z95.3 Presence of xenogenic heart valve	0.007	0.993	0.000
U81.0 Vancomycin resistant agent	0.006	0.993	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.007	0.993	0.000
U84 Resistance to other antimicrobial drugs	0.006	0.994	0.000
U83 Resistance to other antibiotics	0.006	0.994	0.000
U82 Resistance to betalactam antibiotics	0.006	0.994	0.000
U85 Resistance to antineoplastic drugs	0.006	0.994	0.000
D13.4 Liver	0.000	0.994	0.006
G25.6 Drug-induced tics and other tics of organic origin	0.000	0.994	0.006
G25.4 Drug-induced chorea	0.000	0.994	0.006
G25.1 Drug-induced tremor	0.000	0.994	0.006
E83.5 Disorders of calcium metabolism	0.000	0.994	0.006
G25.9 Extrapyramidal and movement disorder, unspecified	0.000	0.994	0.006
U89 Agent resistant to other and unspecified antibiotics	0.006	0.994	0.000
G25.3 Myoclonus	0.000	0.994	0.006
G47.3 Sleep apnoea	0.006	0.994	0.000
X63.0 Home	0.006	0.994	0.000
N30.3 Trigonitis	0.006	0.994	0.000
G25.5 Other chorea	0.000	0.994	0.005
Z95.0 Presence of cardiac pacemaker	0.006	0.994	0.000
X78.0 Home	0.006	0.994	0.000
M77.1 Lateral epicondylitis	0.005	0.995	0.000
T42.4 Benzodiazepines	0.005	0.995	0.000
G25.2 Other specified forms of tremor	0.000	0.995	0.005
R30.0 Dysuria	0.000	0.995	0.005
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.005	0.995	0.000
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.005	0.995	0.000
K31.7 Polyp of stomach and duodenum	0.000	0.995	0.005
G25.8 Other specified extrapyramidal and movement disorders	0.000	0.995	0.005
X78 Intentional self-harm by sharp object	0.005	0.995	0.000
C02.1 Border of tongue	0.005	0.995	0.000
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.005	0.995	0.000
L02 Cutaneous abscess, furuncle and carbuncle	0.005	0.995	0.000
U82.9 Resistance to betalactam antibiotics, unspecified	0.005	0.995	0.000
U82.8 Resistance to other betalactam antibiotics	0.005	0.995	0.000
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.005	0.995	0.000
U82.1 Resistance to methicillin	0.005	0.995	0.000
U82.0 Resistance to penicillin	0.005	0.995	0.000
U83.9 Resistance to unspecified antibiotic	0.005	0.995	0.000
U83.8 Resistance to other single specified antibiotic	0.005	0.995	0.000
U83.7 Resistance to multiple antibiotics	0.005	0.995	0.000
U83.2 Resistance to quinolones	0.005	0.995	0.000
U83.1 Resistance to other vancomycin related antibiotics	0.005	0.995	0.000
U83.0 Resistance to vancomycin	0.005	0.995	0.000
U84.9 Resistance to unspecified antimicrobial drugs	0.005	0.995	0.000
U84.8 Resistance to other specified antimicrobial drug	0.005	0.995	0.000
U84.7 Resistance to multiple antimicrobial drugs	0.005	0.995	0.000
U84.3 Resistance to tuberculostatic drug(s)	0.005	0.995	0.000
U84.2 Resistance to antiviral drug(s)	0.005	0.995	0.000
U84.1 Resistance to antifungal drug(s)	0.005	0.995	0.000
U84.0 Resistance to antiparasitic drug(s)	0.005	0.995	0.000
R00.1 Bradycardia, unspecified	0.005	0.995	0.000
U89.9 Agent resistant to unspecified antibiotic	0.005	0.995	0.000
G72 Other myopathies	0.005	0.995	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.005	0.995	0.000
X60-X84 Intentional self-harm	0.005	0.995	0.000
G71.1 Myotonic disorders	0.005	0.995	0.000
G72.1 Alcoholic myopathy	0.004	0.995	0.000
G25.0 Essential tremor	0.000	0.996	0.004
U89.8 Agent resistant to other single specified antibiotic	0.004	0.996	0.000
C02.9 Tongue, unspecified	0.004	0.996	0.000
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.004	0.996	0.000
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.004	0.996	0.000
G72.9 Myopathy, unspecified	0.004	0.996	0.000
G72.0 Drug-induced myopathy	0.004	0.996	0.000
C02.2 Ventral surface of tongue	0.004	0.996	0.000
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.004	0.996	0.000
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.004	0.996	0.000
M77.19 Lateral epicondylitis (Site unspecified)	0.004	0.996	0.000
M77.18 Lateral epicondylitis-Other	0.004	0.996	0.000
M77.17 Lateral epicondylitis-Ankle/Foot	0.004	0.996	0.000
M77.16 Lateral epicondylitis (Lower leg)	0.004	0.996	0.000
M77.15 Lateral epicondylitis (Pelvic region and thigh)	0.004	0.996	0.000
M77.14 Lateral epicondylitis-Hand	0.004	0.996	0.000
M77.13 Lateral epicondylitis-Forearm	0.004	0.996	0.000
M77.11 Lateral epicondylitis-Shldr region	0.004	0.996	0.000
M77.10 Lateral epicondylitis (Multiple sites)	0.004	0.996	0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.004	0.996	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.000	0.996	0.004
G72.4 Inflammatory myopathy, not elsewhere classified	0.004	0.996	0.000
X63.9 Unspecified place	0.004	0.996	0.000
X63.8 Other specified place	0.004	0.996	0.000
X63.7 Farm	0.004	0.996	0.000
X63.6 Industrial and construction area	0.004	0.996	0.000
X63.5 Trade and service area	0.004	0.996	0.000
X63.4 Street and highway	0.004	0.996	0.000
X63.3 Sports and athletics area	0.004	0.996	0.000
X63.2 School, other institution and public administrative area	0.004	0.996	0.000
X63.1 Residential institution	0.004	0.996	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.004	0.996	0.000
N28 Other disorders of kidney and ureter, not elsewhere classified	0.000	0.996	0.004
X78.9 Unspecified place	0.004	0.996	0.000
X78.8 Other specified place	0.004	0.996	0.000
X78.7 Farm	0.004	0.996	0.000
X78.6 Industrial and construction area	0.004	0.996	0.000
X78.5 Trade and service area	0.004	0.996	0.000
X78.4 Street and highway	0.004	0.996	0.000
X78.3 Sports and athletics area	0.004	0.996	0.000
X78.2 School, other institution and public administrative area	0.004	0.996	0.000
X78.1 Residential institution	0.004	0.996	0.000
G71 Primary disorders of muscles	0.004	0.996	0.000
H04.5 Stenosis and insufficiency of lachrymal passages	0.004	0.996	0.000
L71 Rosacea	0.004	0.996	0.000
K51.8 Other ulcerative colitis	0.004	0.996	0.000
E87.2 Acidosis	0.004	0.996	0.000
G72.8 Other specified myopathies	0.004	0.996	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.004	0.996	0.000
G72.3 Periodic paralysis	0.004	0.996	0.000
G72.2 Myopathy due to other toxic agents	0.004	0.996	0.000
Z63.8 Other specified problems related to primary support group	0.004	0.996	0.000
K81 Cholecystitis	0.000	0.996	0.004
C02.8 Overlapping lesion of tongue	0.004	0.996	0.000
C02.4 Lingual tonsil	0.004	0.996	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.004	0.996	0.000
C02.0 Dorsal surface of tongue	0.004	0.996	0.000
X84 Intentional self-harm by unspecified means	0.003	0.996	0.000
X83 Intentional self-harm by other specified means	0.003	0.996	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.003	0.996	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.003	0.996	0.000
X80 Intentional self-harm by jumping from a high place	0.003	0.996	0.000
X79 Intentional self-harm by blunt object	0.003	0.996	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.003	0.996	0.000
X76 Intentional self-harm by smoke, fire and flames	0.003	0.996	0.000
X75 Intentional self-harm by explosive material	0.003	0.996	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.003	0.996	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.003	0.996	0.000
X72 Intentional self-harm by handgun discharge	0.003	0.996	0.000
X71 Intentional self-harm by drowning and submersion	0.003	0.996	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.003	0.996	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.003	0.996	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.003	0.996	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.003	0.996	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.004	0.996	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.003	0.996	0.000
K29.6 Other gastritis	0.000	0.996	0.004
X61.2 School, other institution and public administrative area	0.003	0.996	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.003	0.996	0.000
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.000	0.996	0.004
E11.5 With peripheral circulatory complications	0.003	0.997	0.000
X67.0 Home	0.003	0.997	0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
J94.8 Other specified pleural conditions	0.000	0.997	0.003
G70-G73 Diseases of myoneural junction and muscle	0.003	0.997	0.000
Z95.8 Presence of other cardiac and vascular implants and grafts	0.003	0.997	0.000
D68.9 Coagulation defect, unspecified	0.003	0.997	0.000
B02.9 Zoster without complication	0.003	0.997	0.000
M89.9 Disorder of bone, unspecified	0.000	0.997	0.003
K81.0 Acute cholecystitis	0.000	0.997	0.003
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.003	0.997	0.000
X63.99 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system; Unspecified place ;During unspecified activity	0.003	0.997	0.000
X61.9 Unspecified place	0.003	0.997	0.000
X61.8 Other specified place	0.003	0.997	0.000
X61.0 Home	0.003	0.997	0.000
X61.7 Farm	0.003	0.997	0.000
X61.6 Industrial and construction area	0.003	0.997	0.000
X61.5 Trade and service area	0.003	0.997	0.000
X61.4 Street and highway	0.003	0.997	0.000
X61.3 Sports and athletics area	0.003	0.997	0.000
X61.1 Residential institution	0.003	0.997	0.000
X67.9 Unspecified place	0.003	0.997	0.000
X67.8 Other specified place	0.003	0.997	0.000
X67.7 Farm	0.003	0.997	0.000
X67.6 Industrial and construction area	0.003	0.997	0.000
X67.5 Trade and service area	0.003	0.997	0.000
X67.4 Street and highway	0.003	0.997	0.000
X67.3 Sports and athletics area	0.003	0.997	0.000
X67.2 School, other institution and public administrative area	0.003	0.997	0.000
X67.1 Residential institution	0.003	0.997	0.000
M89.94 Disorder of bone, unspecified (Hand)	0.000	0.997	0.003
N28.0 Ischaemia and infarction of kidney	0.000	0.997	0.003
X78.99 Intentional self-harm by sharp object: Unspecified place: During unspecified activity	0.003	0.997	0.000
X69.9 Unspecified place	0.003	0.997	0.000
G71.9 Primary disorder of muscle, unspecified	0.003	0.997	0.000
G71.8 Other primary disorders of muscles	0.003	0.997	0.000
G71.2 Congenital myopathies	0.003	0.997	0.000
G71.0 Muscular dystrophy	0.003	0.997	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.003	0.997	0.000
L71.8 Other rosacea	0.003	0.997	0.000
L71.0 Perioral dermatitis	0.003	0.997	0.000
X69.8 Other specified place	0.003	0.997	0.000
X69.7 Farm	0.003	0.997	0.000
X69.6 Industrial and construction area	0.003	0.997	0.000
X69.5 Trade and service area	0.003	0.997	0.000
X69.4 Street and highway	0.003	0.997	0.000
X69.3 Sports and athletics area	0.003	0.997	0.000
X69.2 School, other institution and public administrative area	0.003	0.997	0.000
X69.1 Residential institution	0.003	0.997	0.000
X64.9 Unspecified place	0.003	0.997	0.000
X64.0 Home	0.003	0.997	0.000
X64.8 Other specified place	0.003	0.997	0.000
X64.7 Farm	0.003	0.997	0.000
X64.6 Industrial and construction area	0.003	0.997	0.000
X64.5 Trade and service area	0.003	0.997	0.000
X64.4 Street and highway	0.003	0.997	0.000
X64.3 Sports and athletics area	0.003	0.997	0.000
X64.2 School, other institution and public administrative area	0.003	0.997	0.000
X64.1 Residential institution	0.003	0.997	0.000
X65.9 Unspecified place	0.003	0.997	0.000
X65.0 Home	0.003	0.997	0.000
X65.8 Other specified place	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations